Synthesis of deuterium-labelled 5′-O-[N-(Salicyl)sulfamoyl]adenosine (Sal-AMS-d4) as an internal standard for quantitation of Sal-AMS

Amol Gupte, Murali Subramanian, Rory P. Remrnel, Courtney C. Aldrich

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

5′-O-[N-(Salicyl)sulfamoyl]adenosine (Sal-AMS, 1) is a potent inhibitor of the bifunctional enzyme salicyl-AMP ligase in Mycobacterium tuberculosis. This inhibitor acts by disrupting the biosynthesis of the mycobactin siderophores that are essential for the process of iron acquisition. To aid with in vitro metabolism and in vivo pharmacokinetic studies of SaI-AMS, a stable deuterium-labelled Sal-AMS analog (Sal-AMS-d4) was synthesized. This deuterium-labelled analog was used as an internal standard to conduct in vitro plasma and microsomal stability studies. Sal-AMS was found to be stable for 24 h in human plasma and 1 h in human liver microsomes at 37°C.

Original languageEnglish (US)
Pages (from-to)118-122
Number of pages5
JournalJournal of Labelled Compounds and Radiopharmaceuticals
Volume51
Issue number2
DOIs
StatePublished - Feb 2008

Keywords

  • 5′-O-[N-(Salicyl)sulfamoyl]adenosine
  • Adenylation inhibitor
  • Mass spectrometry
  • Siderophore
  • Tuberculosis

Fingerprint Dive into the research topics of 'Synthesis of deuterium-labelled 5′-O-[N-(Salicyl)sulfamoyl]adenosine (Sal-AMS-d<sub>4</sub>) as an internal standard for quantitation of Sal-AMS'. Together they form a unique fingerprint.

Cite this